Open Access

[Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer

  • Authors:
    • Katsuyuki Iida
    • Rong Zheng
    • Ruoqian Shen
    • David M. Nanus
  • View Affiliations

  • Published online on: September 16, 2024     https://doi.org/10.3892/ijo.2024.5694
  • Article Number: 106
  • Copyright : © Iida et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

November-2024
Volume 65 Issue 5

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Iida K, Zheng R, Shen R and Nanus DM: [Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer. Int J Oncol 65: 106, 2024.
APA
Iida, K., Zheng, R., Shen, R., & Nanus, D.M. (2024). [Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer. International Journal of Oncology, 65, 106. https://doi.org/10.3892/ijo.2024.5694
MLA
Iida, K., Zheng, R., Shen, R., Nanus, D. M."[Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer". International Journal of Oncology 65.5 (2024): 106.
Chicago
Iida, K., Zheng, R., Shen, R., Nanus, D. M."[Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer". International Journal of Oncology 65, no. 5 (2024): 106. https://doi.org/10.3892/ijo.2024.5694